NCT00122720 The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery Status COMPLETED Phase PHASE4
NCT00122187 Translation of Colorectal Cancer Screening Guidelines to Practice: A System Intervention Status COMPLETED Phase NA
NCT00120172 Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00119912 NORCCAP: Norwegian Colorectal Cancer Prevention Trial Status ACTIVE_NOT_RECRUITING Phase NA
NCT00119899 Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases Status COMPLETED Phase PHASE3
NCT00118755 A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00118261 Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00118105 S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT00116506 Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00115765 PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study Status COMPLETED Phase PHASE3
NCT00114946 A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer Status TERMINATED Phase PHASE4
NCT00114231 Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer Status COMPLETED Phase PHASE2
NCT00113776 Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer Status COMPLETED Phase PHASE2
NCT00113763 Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00112918 Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer Status COMPLETED Phase PHASE3
NCT00111774 Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma Status COMPLETED Phase PHASE2
NCT00111761 Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00110721 GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2